Partillion Bioscience
Signal active
Organization
Contact Information
Overview
Partillion Bioscience is an early-stage life science company developing a functional single-cell analysis platform to analyze and sort single cells based on secreted proteins. The platform allows the rapid compartmentalization and analysis of millions of single cells to probe biological functions.
About
Industries
Biotechnology, Service Industry, Health Care, Medical
Founded
2020
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Partillion Bioscience headquartered in United States, North America, operates in the Biotechnology, Service Industry, Health Care, Medical sector. The company focuses on Biotechnology and has secured $485.4M in funding across 80 round(s). With a team of 11-50 employees, Partillion Bioscience is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Partillion Bioscience, raised $5.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
5
Investors
3
Lead Investors
0
Total Funding Amount
$6.1M
Details
1
Partillion Bioscience has raised a total of $6.1M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2023 | Seed | 5.0M |
Investors
Partillion Bioscience is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Paladin Capital Group | - | FUNDING ROUND - Paladin Capital Group | 5.0M |
| Eric Moessinger | - | FUNDING ROUND - Eric Moessinger | 5.0M |
| Partillion Bioscience | - | FUNDING ROUND - Partillion Bioscience | 5.0M |
| +ND Capital | - | FUNDING ROUND - +ND Capital | 5.0M |
Recent Activity
There is no recent news or activity for this profile.